Literature DB >> 23000095

A novel class of antimicrobial peptides from the scorpion Heterometrus spinifer.

Yao Nie1, Xian-Chun Zeng, Ye Yang, Feng Luo, Xuesong Luo, Shifen Wu, Lei Zhang, Jianping Zhou.   

Abstract

The venom peptides from the scorpion Heterometrus spinifer have been poorly characterized so far. Here, we identified a novel class of antimicrobial peptides from the venom gland of H. spinifer, which were referred to as HsAp, HsAp2, HsAp3 and HsAp4, respectively. Each of the four peptides consists of 29 amino acid residues, and is cationic and weakly amphipathic. They display no significant homology to any other known peptides, and thus represent a new family of venom peptides from scorpions. Antimicrobial assay showed that HsAp is able to inhibit the growth of both Gram-negative and Gram-positive bacteria with the MIC values of 11.8-51.2 μM. HsAp is also able to inhibit the growth of the tested fungus. Genomic analysis indicated that the genes of all the four peptides are intronless. Our studies expand the families of antimicrobial peptides from scorpions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000095     DOI: 10.1016/j.peptides.2012.09.012

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  Insights into Antimicrobial Peptides from Spiders and Scorpions.

Authors:  Xiuqing Wang; Guangshun Wang
Journal:  Protein Pept Lett       Date:  2016       Impact factor: 1.890

2.  Diversity and Antimicrobial Potential of Cultivable Endophytic Actinobacteria Associated With the Medicinal Plant Thymus roseus.

Authors:  Zulpiya Musa; Jinbiao Ma; Dilfuza Egamberdieva; Osama Abdalla Abdelshafy Mohamad; Gulsumay Abaydulla; Yonghong Liu; Wen-Jun Li; Li Li
Journal:  Front Microbiol       Date:  2020-03-12       Impact factor: 5.640

3.  Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients.

Authors:  Ehab H Mattar; Hussein A Almehdar; Abdullah A AlJaddawi; Isam ElDin M Abu Zeid; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

4.  Insight into the interactions, residue snorkeling, and membrane disordering potency of a single antimicrobial peptide into different lipid bilayers.

Authors:  Majid Jafari; Faramarz Mehrnejad; Farahnoosh Doustdar
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

Review 5.  Cockroaches, locusts, and envenomating arthropods: a promising source of antimicrobials.

Authors:  Mahnoor Ummul-Warah Faateemah Zehra Mosaheb; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

Review 6.  Antimicrobial peptides from scorpion venoms.

Authors:  Patrick L Harrison; Mohamed A Abdel-Rahman; Keith Miller; Peter N Strong
Journal:  Toxicon       Date:  2014-06-19       Impact factor: 3.033

7.  Scorpion peptides: potential use for new drug development.

Authors:  Bennasr Hmed; Hammami Turky Serria; Zeghal Khaled Mounir
Journal:  J Toxicol       Date:  2013-06-15

8.  Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria.

Authors:  Gaomin Liu; Fan Yang; Fangfang Li; Zhongjie Li; Yange Lang; Bingzheng Shen; Yingliang Wu; Wenxin Li; Patrick L Harrison; Peter N Strong; Yingqiu Xie; Keith Miller; Zhijian Cao
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

9.  Evaluation of the Antimicrobial Activity of Endophytic Bacterial Populations From Chinese Traditional Medicinal Plant Licorice and Characterization of the Bioactive Secondary Metabolites Produced by Bacillus atrophaeus Against Verticillium dahliae.

Authors:  Osama A A Mohamad; Li Li; Jin-Biao Ma; Shaimaa Hatab; Lin Xu; Jian-Wei Guo; Bakhtiyor A Rasulov; Yong-Hong Liu; Brian P Hedlund; Wen-Jun Li
Journal:  Front Microbiol       Date:  2018-05-09       Impact factor: 5.640

10.  Structural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria.

Authors:  Catherine Cesa-Luna; Jesús Muñoz-Rojas; Gloria Saab-Rincon; Antonino Baez; Yolanda Elizabeth Morales-García; Víctor Rivelino Juárez-González; Verónica Quintero-Hernández
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.